documents: FDA-2023-N-2177-7099

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-N-2177-7099 FDA FDA-2023-N-2177 Reference 249 - FDA, “The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] Guidance for Industry and Food and Drug Administration Staff,” July 28, 2014 Supporting & Related Material Background Material 2024-05-06T04:00:00Z 2024 5     2024-05-06T16:48:14Z   0 0 090000648652d7ec

Links from other tables